T cell–Dependent Bispecific Therapy Enhances Innate Immune Activation and Antibody-Mediated Killing
Year: 2023
Type: article
Source: Cancer Immunology Research
Institutions: Genentech, F. Hoffmann-La Roche AG
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: mosunetuzumab, NK cell activation, antibody-dependent cellular cytotoxicity, antibody-dependent cellular phagocytosis, macrophages, innate immune activation, interleukin-2, interferon-gamma, IL-10, TNF-α, cytokine production, solid tumors, hematologic disorders, antibody combination therapy
Open Access status: closed
Funder: Genentech
OpenAlex ID: W4388014101
